ARCHIVES

Trading In Stock Of U.S. Bioscience Halted, Newsletter Report Cited

This article is from The Cancer Letter archive.

Vol. 18 No. 39 | October 9, 1992

Download PDF Visit The Full Archive

Related Articles

Phase III Nexavar Trial Fails Primary Endpoint

August 29, 2014

NCI Proposes Extension Of Breast Cancer Screening To Determine Efficacy Of Biennial Tests

November 7, 1975

ASCO Expanding Tools To Improve Coordination Of Cancer Treatment

November 30, 2007

NCI Director Sets A Goal: Eliminate Suffering, Death From Cancer By 2015

February 14, 2003

New NCI Director Varmus “Glad To Be Back,” Says Goal Is To Control Cancer Through Science

July 16, 2010

Micafungin Bests Fluconazole In Phase III Antifungal Trial

November 29, 2002